Invokana and Ketoacidosis: Lawsuit Information
Gordon & Partners is currently investigating cases involving the connection between the diabetic drug Invokana and ketoacidosis, as well as a possible link between the drug and kidney failure.
While no recall has been issued for this drug, the U.S. Food & Drug Administration (FDA) continues to receive reports from victims who have allegedly suffered blood and kidney problems after taking this medication.
Drug manufacturers are also accused of withholding important information regarding Invokana and ketoacidosis by failing to warn patients about this and other potentially life-threatening side effects.
If you or a loved one was diagnosed with kidney failure or hospitalized for ketoacidosis after taking this medication, you may be entitled to financial compensation by filing an Invokana lawsuit.
Contact the knowledgeable and experienced dangerous drug attorneys at Gordon & Partners today. We have helped thousands of victims receive millions in verdicts and settlement, and we are available to help you, too. All of our legal services are 100 percent FREE, and we only get paid if you win.
Invokana and Ketoacidosis
Invokana is a glucose co-transporter 2 (SGLT2) inhibitor used to treat type 2 diabetes. The drug helps restore the body’s response to insulin by increasing sugar removal via the kidneys, decreasing sugar production in the liver, and limiting how much sugar the body absorbs through the stomach and intestines.
In addition to Invokana, many pharmaceutical companies produce other potentially dangerous SGLT2 drugs, including:
- Farxiga (dapagliflozin)
- Xigduo XR (dapagliflozin/metformin)
- Glyxambi (empagliflozin/linagliptin)
- Invokamet (canagliflozin/metformin)
Despite the purported benefits of SGLT2 drugs, the risk of ketoacidosis in patients taking these drugs is much higher than in patients taking different diabetic medications. Still, this well-known risk did not prevent pharmaceutical companies from wanting to produce and sell additional SGLT2 drugs, including Invokana.
Invokana was first approved by the FDA in August 2014. However, the FDA began receiving reports of Invokana and ketoacidosis shortly after the drug’s approval. In May 2015, less than one year after the medication was approved, the FDA issued a drug safety alert warning consumers that it may lead to ketoacidosis, a serious condition where the body produces high levels of acid in the blood. The condition can be life-threatening and often involves the following symptoms:
- Excessive thirst
- Frequent urination
- Nausea and vomiting
- Abdominal pain
- Shortness of breath
- Fruity-scented breath
According to a study conducted at the University of San Diego, the link between Invokana and ketoacidosis is prevalent and concerning. Over the course of 18 weeks, researchers analyzed the safety and efficacy of the drug in 351 diabetic patients. Half of the patients took either 100 mg or 300 mg of Invokana, while the other half took a placebo. The study’s results indicated a serious increase in ketoacidosis in patients taking Invokana.
While researchers noted small distinctions in the groups’ sugar levels, the major concern of the study was in fact the well-documented link between Invokana and ketoacidosis. According to the researchers’ findings, five study participants who were taking 100mg of the diabetes drug, and seven who were taking 300 mg, developed ketoacidosis during the study. No participants in the placebo group developed the condition.
The incidences of Invokana and ketoacidosis discovered in the study prompted the FDA to issue yet another warning in December 2015. The warning informed diabetic patients that taking Invokana or similar SGLT2 inhibitors may increase the risk of developing ketoacidosis.
If you are currently taking this dangerous drug and have experienced adverse side effects, it is important to meet with a reputable attorney to discuss a potential Invokana lawsuit. You may be entitled to receive compensation for your medical bills, lost wages, and pain and suffering.
Find out if you have a case. CHAT LIVE with a legal representative now.
Contact Us About Your Invokana Lawsuit Today
Invokana, along with other SGLT2s, has been linked to at least 73 cases of ketoacidosis. In all of these cases, patients required medical treatment. Although Invokana and other SGLT2s remain on the market, the FDA’s drug safety communication is indicative of the danger these drugs pose.
The skilled lawyers at Gordon & Partners are experienced in handling dangerous drug litigation and can investigate your claim to determine if you are eligible to file an Invokana lawsuit. Victims of this drug may be entitled to financial compensation for the injuries they sustained.
Our accomplished personal injury lawyers have obtained numerous settlements for clients who have suffered from adverse side effects from a dangerous drug. We were able to obtain these successful settlements because we have the knowledge and resources necessary to fight diligently for the rights of all injury victims.
We also firmly believe that all pharmaceutical companies that manufacture harmful drugs should be punished to the highest degree of the law, and we are not afraid to challenge these companies in court.
Furthermore, we work on a contingency fee basis, which means we will not charge you any fees until we successfully resolve your case.
If you or a loved one was diagnosed with ketoacidosis or suffered from kidney problems after being treated with an SGLT2 drug, contact us. We can help you file an Invokana lawsuit and get the justice you deserve.